DOSSIER · 13F-HR · Q2 2026

ACUTA CAPITAL PARTNERS, LLC

$143M in tracked AUM across 23 positions as of Q2 2026.

AC
CIK 0001582844 · last filed Jun 30, 2026
Total AUM
$143M
as of Q2 2026
Holdings
23
positions
Whale Score
64
64
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

1. Portfolio Overview

ACUTA CAPITAL PARTNERS, LLC manages a focused, high-conviction portfolio totaling approximately $69.02 million as of the report date September 30, 2025. The portfolio decreased by 3.7% from the previous quarter's value of $71.64 million. The fund maintains a highly concentrated structure with only 21 holdings, indicating a strategy that relies on deep, idiosyncratic research rather than broad market diversification.

The portfolio is characterized by high turnover and ...

2. Key Holdings

The portfolio is heavily weighted toward its top-tier positions, with a distinct skew toward companies that may be undervalued or undergoing pivotal transitions.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
PRAX
PRAXIS PRECISION MEDICINES I
$28M83K19.3%
02
WHWK
WHITEHAWK THERAPEUTICS INC
$21M4.7M15.0%
03
TNGX
TANGO THERAPEUTICS INC
$12M391K8.5%
04
STRO
SUTRO BIOPHARMA INC
$9M270K6.3%
05
AVBP
ARRIVENT BIOPHARMA INC
$8M219K5.3%
06
FDMT
4D MOLECULAR THERAPEUTICS INC
$7M508K4.7%
07
DRUG
BRIGHT MINDS BIOSCIENCES INC
$7M93K4.5%
08
OCUL
OCULAR THERAPEUTIX INC
$5M532K3.6%
09
ERAS
ERASCA INC
$5M265K3.4%
10
SRZN
SURROZEN INC
$4M173K3.1%

Filing history

2026Q2Jun 30
$143M 1.2%
23 positionsView →
2026Q1Mar 31
$142M 3.8%
27 positionsView →
2025Q4Dec 31
$147M 113.4%
30 positionsView →
2025Q3Sep 30
$69M 3.7%
21 positionsView →
2025Q2Jun 30
$72M 16.1%
28 positionsLocked
2025Q1Mar 31
$62M 37.9%
27 positionsLocked
2024Q4Dec 31
$99M 19.5%
39 positionsLocked
2024Q3Sep 30
$123M 4.0%
41 positionsLocked
2024Q2Jun 30
$119M 22.9%
33 positionsLocked
2024Q1Mar 31
$154M 13.3%
33 positionsLocked
2023Q4Dec 31
$178M 19.1%
39 positionsLocked
2023Q3Sep 30
$149M 1.1%
46 positionsLocked
Showing 12 of 45